A progressive daily ledger of Trump-world self-owns, legal pain, policy blowback, and bad-faith chaos.
The White House kept layering tariffs and import restrictions onto already unstable trade policy, including a new pharmaceutical tariff move and the broader surcharge framework that remains in force. The result is more uncertainty for companies, more pressure on supply chains, and more evidence that Trump’s trade doctrine is still being written by the day.
Why it matters: Tariff chaos
Returning reader
The White House kept layering tariffs and import restrictions onto already unstable trade policy, including a new pharmaceutical tariff move and the broader surcharge framework that remains in force. The result is more uncertainty for companies, more pressure on supply chains, and more evidence that Trump’s trade doctrine is still being written by the day.
Read the complete verified updateComplete record
Newest first
The White House kept layering tariffs and import restrictions onto already unstable trade policy, including a new pharmaceutical tariff move and the broader surcharge framework that remains in force. The result is more uncertainty for companies, more pressure on supply chains, and more evidence that Trump’s trade doctrine is still being written by the day.
Truth standard
The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A below is restricted to those connected materials and will say when the evidence does not establish an answer.